Trinity Biotech (TRIB) Return on Invested Capital (2009 - 2024)

Trinity Biotech has reported Return on Invested Capital for 14 years, with the latest figure at 0.0% in Q4 2024.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, down 1.0% from the prior year.
• Return on Invested Capital declined to 0.0% in Q4 2024 per TRIB's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.17% in Q3 2020 and troughed at 0.0% in Q1 2024.
• A 5-year average of 0.01% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2020 and 2021: Return on Invested Capital climbed 12 bps in 2020, then decreased 16 bps in 2021.
• Over 5 years, Return on Invested Capital stood at 0.0% in 2020, then plunged by 86 bps to 0.0% in 2021, then slumped by 514 bps to 0.0% in 2022, then slumped by 170 bps to 0.0% in 2023, then soared by 31 bps to 0.0% in 2024.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2024, Q3 2024, and Q2 2024 respectively.